Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

Published:2020-07 Issue: Volume:133 Page:120-130
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Dummer Reinhard,Prince Henry M.,Whittaker Sean,Horwitz Steven M.,Kim Youn H.,Scarisbrick Julia,Quaglino Pietro,Zinzani Pier Luigi,Wolter Pascal,Eradat Herbert,Pinter-Brown Lauren,Sanches Jose A.,Ortiz-Romero Pablo L.,Akilov Oleg E.,Geskin Larisa^ORCID,Huen Auris,Walewski Jan,Wang Yinghui,Lisano Julie^ORCID,Richhariya Akshara,Feliciano Joseph,Zhu Yanyan,Bunn Veronica,Little Meredith,Zagadailov Erin^ORCID,Dalal Mehul R.,Duvic Madeleine

Funder

Millennium Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited

Seattle Genetics, Inc.

NIH

NCI Cancer Center

ADCT Therapeutics

Aileron

Forty-Seven

Infinity

Verastem

Kyowa Hakko Kirin Pharma

Genentech

Roche

AbbVie

Pharmacyclics

ATARA

Celgene

Trillium Therapeutics

Pfizer

GSK

Novartis

Eisai

Kyowa Hakko Kirin

Merck Sharp & Dhome

Horizon

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. An overview of cutaneous T cell lymphomas;Bagherani;F1000Research,2016

2. Molecular pathogenesis of cutaneous lymphomas;Stadler;Exp Dermatol,2018

3. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries;Litvinov;Cancer Med,2015

4. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas;Willemze;Blood,2019

5. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma;Kempf;Blood,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health‐related quality of life and its influencing factors in patients with primary cutaneous B‐cell lymphomas: A multicentric study in 100 patients;Journal of the European Academy of Dermatology and Venereology;2024-01-26

2. Health-Related Quality of Life, Patient Journey and Economic Burden in Chinese Patients with Cutaneous T-Cell Lymphoma;2024

3. Meta-analysis of quality of life in patients with cancer treated with antibody-drug conjugates in randomized controlled trials;Future Oncology;2023-10

4. Cancer management during the COVID-19 world pandemic;Cancer Immunology, Immunotherapy;2023-08-29

5. Cost-Effectiveness of Brentuximab Vedotin Versus Physician’s Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada;Advances in Therapy;2023-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3